We, therefore, aimed to assess effect modification for 12 SNPs, 10 of which have been clearly associated with breast cancer risk (10q26-rs298158 (FGFR2), 8q24-rs13281615, 11p15-rs3817198 (LSP1), 5q11-rs889312 (MAP3K1), 16q12-rs2803662 (TOX3), 2q35-rs13387042, 5p12-rs10941679, 17q23-rs6504950, 3p24-rs4973768 and CASP8-rs17468277) and two for which there is less clear evidence of a main effect (TGFB1-rs1982073 and ESR1-rs3020314). This evidence concerns the gene TOX3 and breast cancer.